SCHEMBL8099739

SCHEMBL8099739

Cc1ccc2cc(OCc3c(Cl)ccc(OCCNC(=O)CCc4ccccc4)c3Cl)ccc2n1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 3/20 0.42
KMT2A Q03164 4/20 0.40
ATM Q13315 1/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 1/20 0.40
PPARG P37231 3/20 0.40
HPGD P15428 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
KLKB1 P03952 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
PPARA Q07869 2/20 0.38
PPARD Q03181 1/20 0.38
MEN1 O00255 2/20 0.37
POLB P06746 1/20 0.37
FKBP4 Q02790 1/20 0.37
FKBP5 Q13451 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8097174 0.85 BDKRB2 (0.40) BDKRB2KDM4EPPARGHPGDMTNR1A
SCHEMBL8099734 0.84 BDKRB2 (0.54) BDKRB2
SCHEMBL8098950 0.77 S1PR4 (0.37) BDKRB2KDM4ELMNAPPARGKLKB1
SCHEMBL8106164 0.75 HPGD (0.44) KMT2ALMNAHPGDKLKB1NPC1
SCHEMBL6936592 0.69 KDM4E (0.42) KDM4ELMNANPC1RAB9APOLB
SCHEMBL8097169 0.69 BDKRB2 (0.60) BDKRB2
SCHEMBL8099285 0.68 BDKRB2 (0.70) BDKRB2
SCHEMBL6581385 0.67 TP53 (0.42) KMT2ALMNAHPGDNPC1MEN1
SCHEMBL6935565 0.67 BDKRB2 (0.46) BDKRB2
SCHEMBL7747432 0.67 BDKRB2 (0.72) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0795547-B1 (Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists HOECHST AG (DE) 2000-05-10 EP disclosed
EP-0795547-A1 (Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1997-09-17 EP disclosed